首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >A REVIEW ON “NEW TREATMENT STRATEGIES FOR ALZHEIMER’S DISEASE AS NEURODEGENERATIVE DISEASE AND ITS RISK FACTOR CAUSE, SYMPTOMS, AND TREATMENT AT WORLDWIDE”
【24h】

A REVIEW ON “NEW TREATMENT STRATEGIES FOR ALZHEIMER’S DISEASE AS NEURODEGENERATIVE DISEASE AND ITS RISK FACTOR CAUSE, SYMPTOMS, AND TREATMENT AT WORLDWIDE”

机译:关于“全球范围内因神经退行性疾病而阿尔茨海默氏病的新治疗策略及其风险因素,症状和治疗”的评论

获取原文
           

摘要

ABSTRACT Alzheimer’s disease (AD) is a dynamic and irreversible neurodegenerative illness and relates to the most widely recognized reason for dementia around the world. AD is a dynamic and lethal cerebrum ailment. Alzheimer’s obliterates mind cells, bringing on memory issue or misfortune and issues with speculation and conduct sufficiently serious to influence work, long lasting leisure activities or social life. Alzheimer’s illness is quickly becoming worldwide, but there is no cure for it. Now, accessible medications just give symptomatic help and do not mediate in infection prepare adequately enough to avert or cure it. Various late studies have reported that working memory does not appear to demonstrate regular age-related deficiencies in solid more established grown-ups when enthusiastic data are included. Indeed, contingent upon the capacity included, patients might demonstrate an enthusiastic advantage in their working memory execution. Moreover, this advantage is not generally obviously one-sided (e.g., toward negative or positive data). We decipher this intricate example of results as an outcome of the cooperation between numerous components including the seriousness of AD, the nature of emotional jolts, and sort of working memory errand. Clinical advantages of the accessible pharmacological treatment for AD with antidementia drugs (to be specific cholinesterase inhibitors and Memantine) are obvious. In an unexpected way, learns about the transient capacity to encode and effectively control enthusiastic data in dementia of Alzheimer’s sort are few and have yielded blended results. Keywords: Alzheimer’s disease, Risk factor for Alzheimer’s disease, Diagnosis, Classification of Anti-Alzheimer’s drug.
机译:摘要阿尔茨海默氏病(AD)是一种动态且不可逆的神经退行性疾病,与全世界痴呆症最广为人知的原因有关。 AD是一种动态且致命的大脑疾病。阿尔茨海默氏症会抹杀大脑细胞,带来记忆问题或不幸,以及投机行为,行为举止足以影响工作,长期的休闲活动或社交生活。阿尔茨海默氏病正在迅速蔓延至世界各地,但无法治愈。现在,可及的药物仅能提供症状帮助,而不能在感染中起调解作用,足以防止或治愈它。各种后期研究报告称,当包含热情数据时,工作记忆似乎并未显示出在成熟的成年人中与年龄相关的常规缺陷。确实,取决于所包含的能力,患者可能会在工作记忆执行方面表现出热情的优势。而且,该优点通常显然不是单方面的(例如,朝向负或正数据)。我们将这个复杂的结果示例解读为众多组件之间合作的结果,这些组件包括AD的严重性,情感颠簸的性质以及工作记忆差事。抗痴呆药物(即特定的胆碱酯酶抑制剂和美金刚胺)可用于AD的药物治疗的临床优势是显而易见的。以一种出乎意料的方式,了解到在阿尔茨海默氏症这类痴呆症中编码和有效控制狂热数据的瞬时能力很少,并且产生了混合结果。关键字:阿尔茨海默氏病,阿尔茨海默氏病的危险因素,诊断,抗阿尔茨海默氏症药物的分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号